English-speaking women were nearly four times as likely to be offered immediate postpartum long-acting reversible contraception (LARC) than Spanish-speaking Hispanic women, according to a study in the journal Women’s Health Issues.

Young women have significantly better adherence to long-acting reversible contraception (LARC) than to short-acting reversible contraception (SARC) at 12 months, according to a systemic review and meta-analysis.

Awareness of most types of birth control was generally high among both white and non-white women, according to a prospective study that examined racial differences in contraceptive awareness and use among women seeking care at family health centers.

Less than half of ob/gyns offer their patients the two most effective forms of emergency contraception -- ulipristal acetate and the copper intrauterine device (IUD) -- according to a national survey.

The ever-use of an intrauterine device (IUD) reduces the risk of ovarian cancer by an average of 30%, according to a rigorous meta-analysis in the Journal of Obstetrics and Gynaecology.

The study in the Brazilian Journal of Nursing also found that the IUD complications were the same as those commonly cited in the literature.

A prospective interventional hospital-based study from India has found that a postpartum intrauterine copper device (PPIUCD) is an efficacious method to reduce the unmet need of contraception.

Neither the levonorgestrel-releasing intrauterine system (LNG-IUS) nor the copper intrauterine device (IUD) impact the incidence of cellular atypia, but do interfere with the microbiota over time, according to liquid-based cervical cytology and microbiological analyses.